Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9285073rdf:typepubmed:Citationlld:pubmed
pubmed-article:9285073lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9285073lifeskim:mentionsumls-concept:C0021760lld:lifeskim
pubmed-article:9285073lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:9285073lifeskim:mentionsumls-concept:C1709915lld:lifeskim
pubmed-article:9285073lifeskim:mentionsumls-concept:C0205224lld:lifeskim
pubmed-article:9285073lifeskim:mentionsumls-concept:C0205460lld:lifeskim
pubmed-article:9285073pubmed:issue5lld:pubmed
pubmed-article:9285073pubmed:dateCreated1998-1-14lld:pubmed
pubmed-article:9285073pubmed:abstractTextInternal deletion K128-Q175 of the human interleukin-6 (hIL-6) has been generated at the cDNA level. With pBV220 as expressing vector, the recombinant pBV*-DIL-6 encoding the deletion mutant (12 kD) of hIL-6 has been constructed. The resulted recombinant plasmids were then used to transform E. coli strain HB101, and the expression in the PLPR promoter system, which is temperature-regulatable, was achieved. After purification and renaturation, the biological activity of the expressed product, designated as DM120, was measured by MTT method in an IL-6-dependent cell line 7TD1. The results show that the amino acid residues of IL-6 128 to 175 are crucial for IL-6 activity. Receptor binding assay in vitro indicates that the entire region is not involved in forming the receptor binding surface.lld:pubmed
pubmed-article:9285073pubmed:languageenglld:pubmed
pubmed-article:9285073pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9285073pubmed:citationSubsetIMlld:pubmed
pubmed-article:9285073pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9285073pubmed:statusMEDLINElld:pubmed
pubmed-article:9285073pubmed:monthAuglld:pubmed
pubmed-article:9285073pubmed:issn1039-9712lld:pubmed
pubmed-article:9285073pubmed:authorpubmed-author:WangJJlld:pubmed
pubmed-article:9285073pubmed:authorpubmed-author:LiuHHlld:pubmed
pubmed-article:9285073pubmed:authorpubmed-author:LángSSlld:pubmed
pubmed-article:9285073pubmed:authorpubmed-author:ZouMMlld:pubmed
pubmed-article:9285073pubmed:authorpubmed-author:DuanJJlld:pubmed
pubmed-article:9285073pubmed:issnTypePrintlld:pubmed
pubmed-article:9285073pubmed:volume42lld:pubmed
pubmed-article:9285073pubmed:ownerNLMlld:pubmed
pubmed-article:9285073pubmed:authorsCompleteYlld:pubmed
pubmed-article:9285073pubmed:pagination1045-50lld:pubmed
pubmed-article:9285073pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9285073pubmed:meshHeadingpubmed-meshheading:9285073-...lld:pubmed
pubmed-article:9285073pubmed:meshHeadingpubmed-meshheading:9285073-...lld:pubmed
pubmed-article:9285073pubmed:meshHeadingpubmed-meshheading:9285073-...lld:pubmed
pubmed-article:9285073pubmed:meshHeadingpubmed-meshheading:9285073-...lld:pubmed
pubmed-article:9285073pubmed:meshHeadingpubmed-meshheading:9285073-...lld:pubmed
pubmed-article:9285073pubmed:year1997lld:pubmed
pubmed-article:9285073pubmed:articleTitleResidues K128-Q175 of human interleukin-6 are essential for its biological activity.lld:pubmed
pubmed-article:9285073pubmed:affiliationDepartment of Molecular Genetics, Institute of Basic Medical Sciences, Beijing, People's Republic of China.lld:pubmed
pubmed-article:9285073pubmed:publicationTypeJournal Articlelld:pubmed